51
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Management of Ocular Surface Inflammation with Persistent Epithelial Defects Using a Sutureless Human Amniotic Membrane Dehydrated Matrix: A Prospective Study Utilizing a Digital Ocular Surface Assessment Tool

ORCID Icon, , , &
Pages 1467-1478 | Received 27 Dec 2023, Accepted 29 Apr 2024, Published online: 24 May 2024

References

  • Craig JP, Nichols KK, Akpek EK, et al. TFOS DEWS II definition and classification report. Ocul Surf. 2017;15(3):276–283. doi:10.1016/j.jtos.2017.05.008
  • Mylla Boso AL, Gasperi E, Fernandes L, Costa VP, Alves M. Impact of ocular surface disease treatment in patients with glaucoma. Clin Ophthalmol. 2020;14:103–111. doi:10.2147/OPTH.S229815
  • Rana HS, Akella SS, Clabeaux CE, Skurski ZP, Aakalu VK. Ocular surface disease in thyroid eye disease: a narrative review. Ocul Surf. 2022;24:67–73. doi:10.1016/j.jtos.2022.02.001
  • Katzman LR, Jeng BH. Management strategies for persistent epithelial defects of the cornea. Saudi J Ophthalmol. 2014;28(3):168–172. doi:10.1016/j.sjopt.2014.06.011
  • Dahlgren MA. Persistent epithelial defects. In: Albert DM, Miller JW, editors. Albert & Jakobiec’s Principles and Practice of Ophthalmology. Philadelphia: Elsevier; 2008:749–759.
  • Ljubimov AV, Saghizadeh M. Progress in corneal wound healing. Prog Retin Eye Res. 2015;49:17–45. doi:10.1016/j.preteyeres.2015.07.002
  • Meller D, Pauklin M, Thomasen H, Westekemper H, Steuhl KP. Amniotic membrane transplantation in the human eye. Dtsch Arztebl Int. 2011;108(14):243–248. doi:10.3238/arztebl.2011.0243
  • Liu T, Zhai H, Xu Y, et al. Amniotic membrane traps and induces apoptosis of inflammatory cells in ocular surface chemical burn. Mol Vis. 2012;18:2137–2146.
  • Sharma N, Singh D, Maharana PK, et al. Comparison of amniotic membrane transplantation and umbilical cord serum in acute ocular chemical burns: a randomized controlled trial. Am J Ophthalmol. 2016;168:157–163. doi:10.1016/j.ajo.2016.05.010
  • Walkden A. Amniotic membrane transplantation in ophthalmology: an updated perspective. Clin Ophthalmol. 2020;14:2057–2072. doi:10.2147/OPTH.S208008
  • Malhotra C, Jain AK. Human amniotic membrane transplantation: different modalities of its use in ophthalmology. World J Transplant. 2014;4(2):111–121. doi:10.5500/wjt.v4.i2.111
  • Dua HS, Gomes JA, King AJ, Maharajan VS. The amniotic membrane in ophthalmology. Surv Ophthalmol. 2004;49(1):51–77. doi:10.1016/j.survophthal.2003.10.004
  • Niknejad H, Peirovi H, Jorjani M, Ahmadiani A, Ghanavi J, Seifalian AM. Properties of the amniotic membrane for potential use in tissue engineering. Eur Cell Mater. 2008;15:88–99. doi:10.22203/eCM.v015a07
  • Tseng SC, Li DQ, Ma X. Suppression of transforming growth factor-beta isoforms, TGF-beta receptor type II, and myofibroblast differentiation in cultured human corneal and limbal fibroblasts by amniotic membrane matrix. J Cell Physiol. 1999;179(3):325–335. doi:10.1002/(SICI)1097-4652(199906)179:3<325::AID-JCP10>3.0.CO;2-X
  • Maqsood S, Elsawah K, Dhillon N, et al. Management of persistent corneal epithelial defects with human amniotic membrane-derived dry matrix. Clin Ophthalmol. 2021;15:2231–2238. doi:10.2147/OPTH.S299141
  • McDonald MB, Sheha H, Tighe S, et al. Treatment outcomes in the DRy Eye Amniotic Membrane (DREAM) study. Clin Ophthalmol. 2018;12:677–681. doi:10.2147/OPTH.S162203
  • Pflugfelder SC, Baudouin C. Challenges in the clinical measurement of ocular surface disease in glaucoma patients. Clin Ophthalmol. 2011;5:1575–1583. doi:10.2147/OPTH.S24410
  • Jabs DA, Nussenblatt RB, Rosenbaum JT; Standardization of Uveitis Nomenclature for Reporting Clinical Data. Results of the first international workshop. Am J Ophthalmol. 2005;140(3):509–516. doi:10.1016/j.ajo.2005.03.057
  • OmniLenz bespoke bandage contact lens; 2023. Available from: https://www.nu-vision.co.uk/omnilenz. Accessed December, 2023.
  • Huntjens B, Basi M, Nagra M. Evaluating a new objective grading software for conjunctival hyperaemia. Cont Lens Anterior Eye. 2020;43(2):137–143. doi:10.1016/j.clae.2019.07.003
  • Haagdorens M, Van Acker SI, Van Gerwen V, et al. Limbal stem cell deficiency: current treatment options and emerging therapies. Stem Cells Int. 2016;2016:9798374. doi:10.1155/2016/9798374
  • Tsai RJF, Tseng SCG. Effect of stromal inflammation on the outcome of limbal transplantation for corneal surface reconstruction. Cornea. 1995;14(5):439–449. doi:10.1097/00003226-199509000-00001
  • Brija~ak M, Dekaris I, Gagro A, et al. Therapeutic effect of amniotic membrane in persistent epithelial defects and corneal ulcers in herpetic keratitis. Coll Antropol. 2008;32(Suppl. 2):21–25.
  • Seitz B, Langenbucher A, Nguyen NX, Ro ̈mer AK, Ku ̈chle M, Naumann GOH. Risk factors for new corneal epithelial defects after penetrating keratoplasty. AAO-poster, Abstract; 168; 2003.
  • Chiang CC, Chen WL, Lin JM, Tsai YY. Allogeneic serum eye drops for the treatment of persistent corneal epithelial defect. Eye. 2009;23(2):290–293. doi:10.1038/sj.eye.6703079
  • Giannaccare G, Versura P, Buzzi M, Primavera L, Pellegrini M, Campos EC. Blood derived eye drops for the treatment of cornea and ocular surface diseases. Transfus Apher Sci. 2017;56(4):595–604. doi:10.1016/j.transci.2017.07.023
  • Abdelghany AA, Bahrawy ME, Alio JL. Combined platelet rich plasma and amniotic membrane in the treatment of perforated corneal ulcers. Eur J Ophthalmol. 2022;32(4):2148–2152. doi:10.1177/11206721211049100
  • Rüfer F, Schröder A, Erb C. White-to-white corneal diameter: normal values in healthy humans obtained with the Orbscan II topography system. Cornea. 2005;24(3):259–261. doi:10.1097/01.ico.0000148312.01805.53
  • Lazreg S, Labetoulle M, Renault D, Baudouin C. Fast and sustained healing of resistant corneal ulcers using corneal scrubbing and matrix regenerating therapy. Eur J Ophthalmol. 2021;31(3):959–966. doi:10.1177/1120672120921379